To mark its 60^th anniversary, the Office of Health Economics is launching a new OHE Innovation Policy Prize. OHE conducts research and consultancy on health economics and related policy issues.

Recent Publications

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

Cookson, G. and Hitch, J.

Consulting Report

June 2022

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

Mott, D. et al.

Consulting Report

March 2022

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Brogaard, N. et al.

Consulting Report

January 2022

OHE News

Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office

Wednesday, 22 June 2022

Since the Office of Health Economics (OHE) published a critique of CBO’s new simulation model of...

OHE's 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Tuesday, 21 June 2022

On the evening of June 16, 2022, an exceptionally bright and warm day, OHE hosted a party to...

ISPOR Issue Panel roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?

Monday, 6 June 2022

As part of OHE’s presence at ISPOR 2022 in Washington DC, we hosted an issue panel tackling the hot...

Welcome to OHE

Recent Events

Multi-Indication Therapies Masterclass

Wednesday, 22 June 2022

Wednesday 22nd June 15:00-17:00 BST | 16:00 - 18:00 CEST | 10:00 - 12:00 EDT | 09:00 - 11:00 CT For...

OHE Lunchtime Seminar - The Value of a QALY Towards the End of Life and its Determinants: Experimental Evidence

Tuesday, 21 June 2022

ABOUT THIS EVENT OHE's Lunchtime Seminar Series shines a spotlight on important pieces of research...

Severity in Value Assessment: From Principle to Practice

Thursday, 26 May 2022

There is a wealth of evidence showing societal support to prioritise interventions for severe...